We have previously shown that
unc-17 encodes the C. elegans vesicular acetylcholine transporter (VAChT), and that it is an excellent marker for cholinergic neurons. We have now identified the vesicular monoamine transporter (VMAT) in C. elegans. VMATs are required for the loading of synaptic vesicles with dopamine, serotonin, and other biogenic amine transmitters. When C. elegans VMAT is expressed in mammalian cells, it has serotonin transport activity. The C. elegans VMAT gene appears to be
cat-1;
cat-1(
e1111) animals are deficient for dopamine-mediated behaviors and are totally deficient for VMAT immuno-staining, and these phenotypes can be rescued (at least partially) by a mammalian VMAT transgene. C. elegans VMAT is associated with synaptic vesicles in approximately 25 neurons. These include all of the cells thought to contain dopamine and serotonin, plus a few others. Although, in general, the immuno-reactivity specific for VAChT and VMAT identify different sets of cells, there appear to be a few neurons that express both transporters: these cells contain serotonin, suggesting that they are both cholinergic and serotonergic. These include the 2 HSN cells and VC4 and VC5. The VC cells are of interest because, although all 6 VC neurons have strong expression of VAChT, only VC4 and VC5 appear to express VMAT. The HSN cells are of interest because not only are they known to contain serotonin, but previous genetic and pharmacological studies suggested that they utilize another neurotransmitter (thought to be acetylcholine) in addition to serotonin (Weinshenker et al., 1995). These data are supported and extended by our results: the demonstration of 2 gene products in these mature, fully differentiated neurons, each essential for the release of a neurotransmitter, strongly suggests that these cells use 2 classical neurotransmitters. (Supported by grants from NIGMS and OCAST.)